SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Cancer
An SI Board Since March 2001
Posts SubjectMarks Bans
1840 97 0
Emcee:  Spekulatius Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1815finance.yahoo.com Good for NKTR and BMY. Is there any exclusivity for any drug Miljenko Zuanic-2/14/2018
1814Pair that can mach CART-candidates efficacy (without compromising safety) may beMiljenko Zuanic-1/22/2018
1813one of several such projects, may start to catalog them here.... Oncol Lett. 20scaram(o)uche-1/20/2018
1812Keytruda hits on OS/PFS interim analysis in CHECKPOINT-189: investorshub.advfn.DewDiligence_on_SI-1/16/2018
1811Proc Natl Acad Sci U S A. 2017 Dec 27. pii: 201710437. doi: 10.1073/pnas.1710437scaram(o)uche-1/14/2018
1810Who knew IPN.PA (Ipsen) was a top-20 player in worldwide oncology sales? (I didnDewDiligence_on_SI-1/11/2018
1809IMO-The majority of WSJ readers are investors not Bio-Chemist. :+ )richardred-8/31/2017
1808WSJ should be berated for using gene therapy in this context. It is a term usedtuck28/31/2017
1807The FDA approved the first gene therapy in the U.S., a way to reprogram cells torichardred-8/31/2017
1806<Results using GITR agonists not overwhelming to date.> From 2014, only 3 Miljenko Zuanic-8/4/2017
1805GITR agonist from Merck, MK-4166...... cancerres.aacrjournals.org Results usinscaram(o)uche-8/4/2017
1804Systemic Immunity Is Required for Effective Cancer Immunotherapy h/t Andy Biotetuck-2/3/2017
1803ADXS has a lot of shots on goal for a small biotech company: siliconinvestor.comDewDiligence_on_SI-1/12/2016
1802Scientists finally solved the mystery of why this wasp's venom can target arusset-9/3/2015
1801The very first human trial of a new approach to cancer treatment has scientistsrusset-4/3/2015
1800Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses scaram(o)uche-1/16/2015
1799eurekalert.org Public Release: 22-Dec-2014 University of Louisville facultyIan@SI-12/22/2014
1798I am watching this discussed on News Hour right now. Here's an article I fouN. Dixon-12/30/2013
1797Cancer Immunology Named 'Breakthrough of the Year'Nick Mulcahy Decemberrusset112/24/2013
1796Thanks Rick - I will use it.John McCarthy-12/8/2013
1795Hey, John.... if you'd like to follow along, Biotech Jim is collecting biscaram(o)uche-12/8/2013
1794Gene therapy scores big wins against blood cancers [graphic] By MARILYNN MARCHIJohn McCarthy-12/7/2013
1793J Immunol. 2013 Nov 27. [Epub ahead of print] IL-6-Mediated Induction of Matrixscaram(o)uche-12/2/2013
1792Int J Cancer. 2013 Oct 6. doi: 10.1002/ijc.28507. [Epub ahead of print] Selectiscaram(o)uche-11/22/2013
1791>> finding that IFNß also induces the expression of un-phosphorylatedscaram(o)uche-11/11/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News